Sono-Tek Corporation designs and manufactures precision ultrasonic coating systems that apply thin-film coatings for electronics, medical device, energy, industrial, and research applications worldwide. Company news commonly covers customer orders for medical device coating systems, including MediCoat and ExactaCoat MD platforms, as customers move from development and early production toward higher-capability manufacturing lines. Updates also address technical collaborations for advanced materials processes, quarterly financial results, backlog trends, gross margin commentary, and demand conditions across medical, alternative energy, microelectronics, and industrial markets.
Sono-Tek (SOTK) reported fiscal first-half 2027 revenue growth of 6%, driven by medical-device sales, alongside higher operating and net income. For the six months ended August 31, 2026, revenue reached $10.893 million, gross margin rose to 55% from 51%, operating income increased 41% to $1.279 million, and net income rose 22% to $1.107 million. Medical sales increased 289% to $7.05 million.
Second-quarter revenue increased 1% to $5.232 million, but net income fell 14% to $366,000 as operating expenses increased. Cash, cash equivalents and marketable securities totaled $17.7 million, with no outstanding debt. Backlog reached $9.51 million, up 23% sequentially. Three orders received after quarter-end totaled approximately $7.19 million and are expected to ship in fiscal 2028. Sono-Tek reiterated its expectation of flat to modest fiscal 2027 revenue growth, reflecting the timing of several large orders.
Sono-Tek (SOTK) will hold its fiscal second-quarter and first-half 2027 earnings conference call on October 14, 2026, at 10:30 am ET. The results cover the period ended August 31, 2026 and will be released before the market opens on October 14. A simultaneous webcast will be available through the company’s website, with a replay available there for one year.
Sono-Tek (SOTK) received three purchase orders totaling approximately $7.19 million from an existing clean energy customer for production-scale coating systems. The orders cover 10 systems for shipment to three geographic locations and represent the largest aggregate customer order in the company's history. They expand a multi-year relationship with a customer already operating Sono-Tek systems in advanced solar manufacturing.
Delivery is currently expected primarily during fiscal 2028, which begins March 1, 2027, but timing may vary with production schedules and customer requirements. Together with a previously announced medical diagnostic production line order of more than $3.6 million, the two programs account for more than $10.79 million in backlog. The majority is currently expected to ship during fiscal 2028; the programs involve different customers in alternative energy and medical devices.
Sono-Tek (Nasdaq: SOTK) announced it received a record purchase order of over $3.6 million for a single integrated ultrasonic coating production line to manufacture medical diagnostic devices. This is the largest order in its history for one production line, placed by an existing customer that previously used Sono-Tek platforms.
The new system will integrate ultrasonic coating, complementary processes, and advanced automation to support the customer’s transition from process development to high-volume manufacturing. According to Sono-Tek, the line is expected to ship during fiscal year 2028 and reinforces its strategy of larger, more complex, higher-value systems.
Sono-Tek (Nasdaq:SOTK) reported first quarter fiscal 2027 results for the period ended May 31, 2026. Net sales rose 10% to $5.66 million, driven mainly by medical markets. Gross margin expanded to 57% from 52%, lifting gross profit 21% to $3.21 million.
Operating income increased to $897,000 and net income to $741,000, or $0.05 per diluted share. Cash, equivalents, and marketable securities were $16.65 million with no debt. Backlog was $7.73 million. Sono-Tek projects first-half 2027 revenue growth and flat to modest growth for fiscal 2027.
Sono-Tek (Nasdaq:SOTK) reported fiscal 2026 net sales of $20.9 million, up 2%, with gross margin rising to 51%. Operating income grew 81% to $1.83 million and net income rose 42% to $1.81 million.
Q4 2026 sales were $5.6 million, net income $0.56 million, cash was $14.8 million with no debt, and backlog reached about $9.1 million. Medical revenue increased 54%, electronics 16%, while alternative/clean energy declined 19%. The company projects flat to modestly higher revenue in FY 2027.
Sono-Tek (NASDAQ:SOTK) will host a conference call to discuss fiscal fourth quarter and full year 2026 financial results, for the period ended February 28, 2026.
The call is scheduled for Thursday, May 28, 2026 at 10:30 am ET, with dial-in, webcast, and replay options available to investors.
Diamond Quanta and Sono-Tek (Nasdaq: SOTK) announced a strategic collaboration on March 17, 2026 to integrate Sono-Tek precision coating systems as a standardized process module within Diamond Quanta’s engineered diamond-on-glass manufacturing architecture.
The partnership aims to improve thin-film uniformity, repeatable multilayer deposition, and structured progression from development to OEM qualification across optics, thermal, semiconductor, and quantum applications.
Sono-Tek (Nasdaq: SOTK) announced a technical collaboration with Diamond Quanta to integrate Sono-Tek’s precision ultrasonic coating systems into Diamond Quanta’s engineered diamond manufacturing workflows. The effort targets repeatable thin-film deposition, improved film uniformity, and progression toward OEM qualification and scalable manufacturing.
The collaboration emphasizes standardized process architecture to align engineered diamond-on-glass materials with semiconductor and electronics toolchains, supporting multilayer integration and manufacturability as Diamond Quanta advances toward qualification.
Sono-Tek (Nasdaq: SOTK) received a purchase order for $820,000 of ultrasonic coating equipment to be used in production of diagnostic medical devices. The order, placed through a subcontractor, scales an existing customer from earlier systems and is expected to ship in fiscal 2027.
The system deposits an electronically active layer, represents higher throughput and average selling price versus prior units, and comes from a different customer than earlier $5.0M and $2.8M medical device orders.